Conversely, blast count by flow cytometry was positively associated with WT1 levels also in MDS patients, confirming flow cytometry as a more sensitive and specific tool for identification of leukemic cells compared to light microscopy that is operator dependent [29,30,31]. This evidence concerns the gene WT1 and myelodysplastic syndrome.